O	0	14	Overexpression	Overexpression	NN	B-NP
O	15	22	confers	confer	VBZ	B-VP
O	23	25	an	an	DT	B-NP
O	26	35	oncogenic	oncogenic	JJ	I-NP
O	36	45	potential	potential	NN	I-NP
O	46	50	upon	upon	IN	B-PP
O	51	54	the	the	DT	B-NP
O	55	58	eph	eph	NN	I-NP
O	59	63	gene	gene	NN	I-NP
O	63	64	.	.	.	O

O	66	69	The	The	DT	B-NP
O	70	73	eph	eph	NN	I-NP
O	74	78	gene	gene	NN	I-NP
O	79	86	encodes	encode	VBZ	B-VP
O	87	88	a	a	DT	B-NP
O	89	97	putative	putative	JJ	I-NP
O	98	106	receptor	receptor	NN	I-NP
O	107	115	tyrosine	tyrosine	NN	I-NP
O	116	122	kinase	kinase	NN	I-NP
O	123	126	for	for	IN	B-PP
O	127	129	an	an	DT	B-NP
O	130	132	as	as	IN	B-PP
O	133	136	yet	yet	RB	B-NP
O	137	144	unknown	unknown	JJ	I-NP
O	145	151	ligand	ligand	NN	I-NP
O	151	152	.	.	.	O

O	153	157	Some	Some	DT	B-NP
O	158	163	human	human	JJ	I-NP
B-Cell	164	170	cancer	cancer	NN	I-NP
I-Cell	171	176	cells	cell	NNS	I-NP
O	177	181	have	have	VBP	B-VP
O	182	186	been	be	VBN	I-VP
O	187	192	found	find	VBN	I-VP
O	193	195	to	to	TO	I-VP
O	196	207	overexpress	overexpress	VB	I-VP
O	208	211	eph	eph	NN	B-NP
O	212	217	mRNAs	mRNA	NNS	I-NP
O	218	225	without	without	IN	B-PP
O	226	230	gene	gene	NN	B-NP
O	231	244	amplification	amplification	NN	I-NP
O	244	245	.	.	.	O

O	246	248	We	We	PRP	B-NP
O	249	253	show	show	VBP	B-VP
O	254	258	here	here	RB	B-ADVP
O	259	263	that	that	IN	B-SBAR
B-Cell	264	270	NIH3T3	NIH3T3	NN	B-NP
I-Cell	271	276	cells	cell	NNS	I-NP
O	277	284	acquire	acquire	VBP	B-VP
O	285	296	tumorigenic	tumorigenic	JJ	B-NP
O	297	304	ability	ability	NN	I-NP
O	305	307	in	in	IN	B-PP
O	308	312	nude	nude	JJ	B-NP
O	313	317	mice	mouse	NNS	I-NP
O	318	321	and	and	CC	O
O	322	326	make	make	VB	B-VP
B-Cell	327	335	colonies	colony	NNS	B-NP
O	336	338	in	in	IN	B-PP
O	339	343	soft	soft	JJ	B-NP
O	344	348	agar	agar	NN	I-NP
O	349	353	with	with	IN	B-PP
O	354	355	a	a	DT	B-NP
O	356	361	viral	viral	JJ	I-NP
B-Cellular_component	362	365	LTR	LTR	NN	I-NP
O	366	367	(	(	(	O
B-Cellular_component	367	371	Long	Long	JJ	B-NP
I-Cellular_component	372	380	Terminal	Terminal	JJ	I-NP
I-Cellular_component	381	387	Repeat	Repeat	NN	I-NP
O	387	388	)	)	)	O
O	388	389	-	-	HYPH	O
O	389	395	driven	drive	VBN	B-VP
O	396	406	artificial	artificial	JJ	B-NP
O	407	417	expression	expression	NN	I-NP
O	418	420	of	of	IN	B-PP
O	421	424	the	the	DT	B-NP
O	425	428	eph	eph	NN	I-NP
O	429	433	gene	gene	NN	I-NP
O	434	436	to	to	TO	B-PP
O	437	438	a	a	DT	B-NP
O	439	443	high	high	JJ	I-NP
O	444	449	level	level	NN	I-NP
O	449	450	.	.	.	O

O	451	455	This	This	DT	B-NP
O	456	462	result	result	NN	I-NP
O	463	471	supports	support	VBZ	B-VP
O	472	475	the	the	DT	B-NP
O	476	483	alleged	alleged	JJ	I-NP
O	484	496	contribution	contribution	NN	I-NP
O	497	499	of	of	IN	B-PP
O	500	513	overexpressed	overexpresse	VBN	B-NP
O	514	522	receptor	receptor	NN	I-NP
O	523	531	tyrosine	tyrosine	NN	I-NP
O	532	539	kinases	kinase	NNS	I-NP
O	540	542	to	to	TO	B-PP
B-Cell	543	547	cell	cell	NN	B-NP
O	548	562	transformation	transformation	NN	I-NP
O	562	563	.	.	.	O

